What We're Reading: Page
Industry reads hand-picked by our editors
Jul 09, 2026
Jul 08, 2026
-
The New York Times
Plaintiff for Anti-Vaccine Group’s Suit Is Charged With Murder of Her Twins
-
Fierce Biotech
As US lawmakers increase scrutiny of Chinese trials, industry fears ‘huge distraction and expense’
-
CNBC
Employers aren’t expanding coverage of GLP-1 obesity drugs – many are finding ways around it
Jul 07, 2026
Jul 06, 2026
-
The Wall Street Journal
Drugmaker Ipsen Sees More Deals Coming to Continue Buying Spree
-
Houston Business Journal
Houston biotech, pharma deals rise after VC funding ups and downs
-
Stat
I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
Jul 02, 2026
Jul 01, 2026
-
Stat
AI company Anthropic announces it will begin developing drugs of its own
-
Reuters
US House committee opens investigation into Merck, AbbVie China drug trials
-
Boston Business Journal
Massachusetts biotech layoffs drop to lowest level in over two years
-
The Wall Street Journal
The Latest Senior-Citizen Special Is Here: Cheap Weight-Loss Drugs
Jun 30, 2026
-
The Wall Street Journal
Biotech Investor Pumps the Brakes on AI Drug Discovery
-
Reuters
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings
-
South China Morning Post
Hong Kong draws royalties giant as mainland China biotech licensing heats up